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Abstract 
Pancreatic rough ER ATP-binding proteins, including two isoforms of SERCA-2b Ca2+,Mg-ATPase, were identified using specific 
photoaffinity labelling with 8-azido-ATP. 8-Azido-ATP irreversibly inhibited Ca2+,Mg-ATPase activity only after UV irradiation and the 
inhibition was prevented by inclusion of 5 mM ATP in the labelling reaction. Rough ER proteins of apparent molecular masses 141, 111, 
100, 84, 69, 55 and 47 kDa were detected following photoaffinity-labelling with 8-azido-[ a-32p]ATP. The two bands at 111 kDa and 100 
kDa corresponded in molecular mass to the two SERCA-2b Ca2+,Mg-ATPase isoforms previously demonstrated immunologically [1]. 
Immunoprecipitation of rough ER proteins by a SERCA-2b-specific antibody showed that the two ATPase bands were photoaffinity- 
labelled. Photoaffinity labelling of the 111 and 100 kDa proteins was: (a) abolished when Ca2+,Mg-ATPase activity was inactivated by 
EDTA-treatment of rough ER membranes; (b) inhibited by the Ca2+,Mg-ATPase inhibitor vanadate; (c) not affected by thapsigargin. The 
data demonstrate that pancreatic rough ER contains two isoforms of the SERCA-2b CaZ+,Mg-ATPase whose ATP-binding properties are 
susceptible to inhibition by vanadate but not thapsigargin. 
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1. Introduction 
The initial phase of pancreatic enzyme secretion is 
stimulated by the release of Ca 2 + from intracellular stores 
and may involve both Ins(1,4,5)P 3 -dependent and -inde- 
pendent mechanisms [2-6]. Maintenance of Ca 2÷ in rough 
ER stores and reuptake after release is dependent on active 
Ca 2+ transport, mediated by Ca2+,Mg-ATPases [7,8]. 
It has been shown that pancreatic rough ER contains the 
SERCA-2b form of Ca2+,Mg-ATPase on the basis of 
Northern blot analysis [9] and immunological characteriza- 
tion using an antibody against he unique C-terminal amino 
acid sequence of the SERCA-2b Ca2+,Mg-ATPase [1]. The 
immunological data [1] further demonstrated the presence 
of two isoforms of different molecular weight whose 
Ca2+,Mg-ATPase activity was susceptible to inhibition by 
vanadate and thapsigargin. To test the hypothesis that the 
two isoforms are responsible for accumulating Ca 2+ in 
different intracellular stores [1], as has been suggested for 
adrenal chromaffin cells and for platelets [10,11], requires 
their purification and characterization. Purification of the 
pancreatic rough ER Ca2+,Mg-ATPase has proved difficult 
due to lability of solubilized enzyme activity [12] and 
because single-step purification using Reactive Dye- 
Agarose, as previously used for the SR Ca2+,Mg-ATPase 
[13], was complicated by activation of enzyme activity [1]. 
The present study demonstrates that both Ca2+,Mg-ATPase 
isoforms can be specifically photoaffinity-labelled using 
8-azido-ATP and provides a means of detecting the 
Ca2+,Mg-ATPase without relying on measurement of en- 
zyme activity. 
Abbreviations: CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]- 
1-propanesulfonate; ER, endoplasmic reticulum; SERCA, sarco-, endo- 
plasmic reticulum calcium ATPase; SR, sarcoplasmic reticulum; 8-azido- 
ATP, 8-azido-adenosine triphosphate. 
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2. Materials and methods 
ATP, 8-azido-ATP, CHAPS, Insoluble Staph A protein 
(lyophilised crude extract from Staphylococcus aureus, 
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Cowan I strain), Aprotinin, PMSF and thapsigargin were 
from Sigma. 8-Azido-[a-32p]ATP (2-10 Ci/mmol) was 
from ICN Biochemicals. All other reagents were of the 
highest quality available from BDH. 
2.1. Preparation of pancreatic rough ER 
Rough ER membranes from the pancreas of overnight- 
fasted Wistar rats were purified as previously described 
[1,7] and resuspended in sucrose buffer (0.25 M sucrose; 
100 mM KC1; 2 mM Na azide; 5 mM MgCI2; 100 mM 
imidazole-HC1 (pH 6.8)) at a protein concentration of 
approx. 3 mg/ml. 
In experiments o determine the effect of removal of 
ribosomes and luminal proteins, rough ER membranes 
were treated with EDTA as described by Jackson and 
Blobel [14]. Thus, rough ER membranes were incubated 
with an equal volume of 20 mM NaEDTA, 50 mM 
triethanolamine (pH 7.5) at 0°C for 2 min, underlayed with 
0.5 M sucrose, 50 mM triethanolamine (pH 7.5), cen- 
trifuged at 100 000 X g for 60 min and the resulting pellet 
resuspended in 0.25 M sucrose, 50 mM triethanolamine 
(pH 7.5). 
2.2. Assays 
Ca2+,Mg-ATPase activity was assayed as previously 
described [1,7] and is defined as the difference in ATPase 
activity in the presence or absence of 0.7/xM free Ca 2+ (1 
mM EGTA/0.5 mM CaC12 at pH 6.8). Protein was esti- 
mated using the Bio-Rad protein assay kit and BSA as 
standard. RNA was assayed by absorbance at 260 nm of 
free nucleotides following precipitation with 0.3 M per- 
chloric acid in the presence of 0.3 mM MgCI 2, 0.02% 
(w/v) BSA, hydrolysis with 0.3 M KOH for 1 h at 37°C 
and reprecipitation of DNA and protein with 0.6 M per- 
chloric acid. Amylase was assayed by the method of 
Bernfeld [15]. 
2.3. Production of anti-peptide polyclonal antibodies 
The procedure was based on that of Wuytack et al. [16]. 
The synthesis and coupling of a peptide consisting of the 
12 C-terminal amino acids of the SERCA 2b Ca2+,Mg - 
ATPase to BSA or thyroglobulin, production and charac- 
terization of polyclonal antibodies in white New Zealand 
rabbits was as previously described [1,17]. Ca2+,Mg- 
ATPase content of rough ER membranes was estimated by 
ELISA using peroxidase-linked second antibody, colour 
development with 1,2-phenylenediamine dihydrochloride 
and detection at 492 nm. Membrane proteins (100 ng/well) 
were coupled to plastic microtitre plates by overnight 
incubation at 4°C in 50 mM carbonate/bicarbonate (pH 
9.6). Results were expressed as absorbance units per/zl of 
membrane suspension. 
2.4. Photoaf-finity labelling 
Rough ER membranes (50 /~g) or immunoprecipitates 
(see below) were resuspended in sucrose buffer to a final 
volume of 1 ml. In experiments where the effects of 
ATPase inhibitors were investigated, membranes were in- 
cubated with inhibitor for 10 min on ice before addition of 
8-azido-ATP. After incubation in the presence of 8-azido- 
ATP for 30 min on ice in the dark (in order to allow the 
photoaffinity reagent o equilibrate with the membranes), 
samples were transferred to 1 ml quartz cuvettes and 
suspended in front of an Allen Type A-409/M 220-240 V 
fluorescence tube ultraviolet lamp at a distance of 5 cm (at 
shorter distances partial enzymic inactivation was seen in 
the presence or absence of 8-azido-ATP). The temperature 
of the sample was monitored throughout by the use of a 
Ni-Al, Ni-Cr thermocouple connected to a digital ther- 
mometer; at no point did the temperature exceed 37°C. 
After irradiation, samples were centrifuged (10 min in an 
Eppendorf microfuge) and pellets resuspended in either 
ATPase assay medium (see [7]), or electrophoresis olubi- 
lization buffer (0.1 M Tris-HC1 (pH 6.8) containing 2% 
w/v  SDS, 10% v /v  glycerol). For detection of proteins 
radiolabelled following irradiation in the presence of 8- 
azido-[ a- 32 P]ATP (5/xCi/ml), samples were resuspended 
in 100 /zl electrophoresis gel loading buffer and 90 /~1 
subjected to electrophoresis on 7.5% polyacrylamide g ls. 
Gels were stained with Coomassie brilliant blue R250, 
dried and autoradiographed using Amersham MP Hyper- 
film and incubation at -70°C. 
2.5. Immunoprecipitation 
The procedure, based on the method of Doolittle et al. 
[18], was as previously described [1]. Briefly, solubilised 
rough ER membranes (1.8 mg protein/ml) were incubated 
with antiserum (1:56 final concentration) and immune 
complexes precipitated by addition of Protein A slurry. 
After washing, immunoprecipitates were diluted into su- 
crose buffer in the presence of 8-azido-ATP and subjected 
to UV irradiation as described above. Following irradia- 
tion, immune complexes were dissociated from Protein A 
by heating at 37°C for 5 min in polyacrylamide g l elec- 
trophoresis gel loading buffer and centrifuging for 5 min at 
5000 × g. Supernatants were subjected to polyacrylamide 
gel electrophoresis and autoradiography as described above. 
3. Results 
Optimization of photoaffinity labelling 
The formation of an irreversible bond between photo- 
affinity reagent and ATPase will deny access to the active 
site of the enzyme to subsequently added substrate; thus 
efficiency of photoaffinity labelling was monitored by its 
ability to inhibit Ca2+,Mg-ATPase activity. Fig. 1 shows 
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Fig. 1. Time-course of inhibition of rough ER Ca2+,Mg-ATPase by
irradiation i the presence of 8-azido-ATP. 50 /zg of rough ER mem- 
branes were subjected toUV irradiation i the presence (O) or absence 
(0) of 8-azido ATP as described inMaterials and methods for the times 
indicated. Inhibition of Ca 2 +,Mg-ATPase activity of irradiated samples i
expressed as percentage reduction of the activity of unirradiated mem- 
branes, kept on ice. Data are means +S.E. from at least hree different 
membrane preparations at each time point. 
the time-course of inhibition of Ca2+,Mg-ATPase activity 
during UV irradiation in the presence or absence of 8- 
azido-ATP. UV irradiation alone resulted in inhibition of 
activity by approx. 10% which was unchanged with time. 
Significant inhibition of activity (53% of the activity of 
native rough ER) in the presence of 8-azido-ATP was 
optimal after 30 min irradiation (Fig. 1). Control experi- 
ments showed that in the absence of UV irradiation 8- 
azido-ATP did not significantly inhibit Ca2+,Mg-ATPase 
activity (82.75 ___ 3.38% of control; n = 3) during 30 min 
incubation. 
Fig. 2 shows that inhibition of CaZ+,Mg-ATPase activ- 
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Fig. 2. Dependence of inhibition of rough ER Ca2+,Mg-ATPase during 
UV Irradiation on 8-azido-ATP concentration. 50 /~g of rough ER 
membranes were subjected to UV irradiation i  the presence of the 
8-azido-ATP concentrations shown, for 30 rain, as described inMaterials 
and methods. Inhibition of Ca2+,Mg-ATPase activity of irradiated sam- 
ples is expressed aspercentage reduction of the activity of unirradiated 
membranes, kept on ice. Data are means+S.E, from at least hree 
different membrane preparations at each concentration. 
2q 
1 
1 2 3 4 5 
Fig. 3. Autoradiograph of rough ER proteins photoaffinity-labelled by 
8-azido-ATP. Lane 1:50 /xg of rough ER membranes were subjected to
UV irradiation i the presence of5/xCi 8-azido-[ or-32 P]ATP for 30 min 
and irradiated samples fractionated on 7.5% SDS-polyaerylamide gels 
and autoradiographed, as escribed inMaterials and methods. Lane 2: as 
Lane 1 but without UV irradiation. Lane 3: as Lane 1 but in the presence 
of 5 mM ATP. Lane 4: as Lane 1 but in the presence of 0.1 mM 
vanadate. Lane 5: as Lane 1 but in the presence of 1 /xM thapsigargin. 
The autoradiograph is representative of data obtained from at least seven 
different membrane preparations (Lanes 1-3) and for three additional 
preparations (Lanes 4 and 5). Values on left hand side show position of 
molecular mass markers (values in kDa). Arrows on right hand side show 
position of bands referred to in the text. 
centration of 8-azido-ATP. Assuming that 100% inhibition 
can be attained at an 8-azido-ATP concentration greater 
than 150 /~M, the concentration causing half-maximal 
inhibition was calculated to be 97.1 + 17.2 /xM (mean + 
S.E. for three determinations with different membrane 
preparations). Under optimal conditions (irradiation for 30 
min at 5 cm from the UV source in the presence of 75/xM 
8-azido-ATP), addition of excess (5 mM) ATP during 
irradiation prevented significant inhibition of Ca2+,Mg- 
ATPase activity (93.4 + 15.5% of control; n = 4). 
Identification of pancreatic rough ER ATP-binding pro- 
teins 
Photoaffinity labelling was carried out under the opti- 
mum conditions described above, in the presence of 8- 
azido-[ or-32 P]ATP. Several rough ER proteins were radio- 
labelled (Fig. 3, lane 1): bands of apparent molecular 
masses 140.7 ___ 2.0, 110.9 + 2.1, 100.3 + 2.5, 84.1 ___ 1.3, 
69.3 ___ 3.1, 54.8 + 2.7 and 47.1 + 0.6 kDa (n = 7 gels) 
were consistently observed. Two of these bands (111 and 
100 kDa) had molecular masses similar to those of pro- 
teins previously shown by Western blotting and immuno- 
precipitation to be SERCA-2b Ca2+,Mg-ATPases [1]. As 
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Table 1 
Effects of ATPase inhibitors on photoaffinity labelling of rough ER ATP-binding proteins 
Inhibitor ATP-binding (% control) 
Molecular mass (kDa): 141 111 100 84 69 54 47 
Thapsigargin (1/~M) 107.2 ___ 8.3 84.3 + 17.9 82.0 + 24.7 87.1 + 6.4 168.7 + 40.1 109.7 + 7.9 98.8 + 5.8 
Vanadate (0.1 raM) 111.9 ___ 15.1 33.6 + 2.7 38.0 + 4.6 113.5 + 13.4 140.6 + 9.0 78.9 + 2.9 125.5 + 21.0 
Ouabain (0.1 mM) 113.3 125.3 136.4 78.5 122.9 96.3 63.5 
50/.Lg of rough ER proteins was pre-incubated for15 min at 4°C with ATPase inhibitors as indicated, subjected toUV irradiation i the presence of5 
/zCi 8-azido-[ ot-32p]ATP for 30 min, fractionated on 7.5% SDS-polyacrylamide g ls, autoradiographed, andsubjected to densitometric analysis as 
described in Materials and methods. ATP-binding of each protein, in the presence or absence of inhibitor, was first normalized by expression as: 
Intensity of individual band/Sum of intensity of all seven ATP-binding proteins in that lane. The data shown (% control) were calculated from the 
normalized values as: (ATP-binding in the presence of inhibitor/ATP-binding in the absence of inhibitor)× 100. Data are means + S.E. for 
autoradiographs from experiments onthree different membrane preparations (vanadate and thapsigargin) and on one preparation for ouabain. 
can be seen in lanes 2 and 3, labelling was prevented if 
membranes were not subjected to UV irradiation or if 
excess (5 mM) ATP was present during irradiation. 
Effects of Ca 2 +,Mg-ATPase inhibitors 
Pancreatic rough ER Ca2+,Mg-ATPase activity was 
previously shown to be inhibited by both thapsigargin and 
vanadate [1]. To further determine which ATP-labelled 
protein bands correspond to Ca2+,Mg-ATPase isoforms, 
vanadate (0.1 mM), thapsigargin (1 /.LM) or ouabain (0.1 
mM) were incubated with ER membranes prior to photo- 
affinity labelling. Representative autoradiographs showing 
the effects of vanadate and thapsigargin are shown in Fig. 
3 (lanes 4 and 5, respectively). Densitometric analysis of 
three autoradiographs (Table 1) showed that vanadate (0.1 
mM) caused a 60-70% reduction in labelling of the 111 
and 100 kDa proteins but was without significant effect on 
the five other ATP-binding proteins. Neither the Na+,K +- 
ATPase inhibitor ouabain nor the Ca2+,Mg-ATPase in- 
hibitor thapsigargin significantly inhibited ATP-binding to 
any protein, including the 111 and 100 kDa proteins. As 
expected, the addition of 0.1 mM ouabain had no in- 
hibitory effect on Ca2+,Mg-ATPase activity (104.3+ 
15.6%; (n = 3) of that of native membranes). 
In order to differentiate between the labelling of intrin- 
sic membrane proteins and proteins associated with either 
ribosomes or the luminal contents, ER membranes were 
treated with EDTA as described in Materials and methods. 
As shown in Table 2, compared to native rough ER 
membranes, EDTA-treated membranes had lost 94%, 90% 
and 71% of their RNA, amylase and total protein content, 
respectively, demonstrating loss of ribosomes and luminal 
contents. However, it was shown by ELISA that EDTA- 
treatment resulted in no loss of SERCA-2b CaE+,Mg- 
ATPase protein (Table 2). By contrast, 8-azido-[ a- 32 P]ATP 
photoaffinity labelling of the 111 and 100 kDa proteins 
was undetectable (representing > 90% inhibition of la- 
belling) and CaZ+,Mg-ATPase activity was reduced by 
81% (Table 2). Thus the data demonstrate that the 
Ca 2 +,Mg-ATPase isoforms are retained in an inactive form 
following EDTA treatment and that inactivation results in 
the loss of ATP-binding as measured by 8-azido-[a- 
32 P]ATP photoaffinity labelling. 
Photoaffinity labelling of immunoprecipitates 
In order to directly demonstrate that the 111 and 100 
kDa proteins were both ATPases, solubilized ER proteins 
were immunoprecipitated by the previously described 
SERCA-2b Ca2+,Mg-ATPase antibody [1] and photo- 
affinity labelled with 8-azido-[ a-a2p]ATP. Densitometric 
scans of autoradiographs showed two distinct peaks corre- 
sponding to molecular masses of 108 and 100 kDa (Fig. 4; 
peaks identified by arrows). A prominent peak at 135-150 
kDa was present in precipitates carried out using SERCA- 
2b Ca2+,Mg-ATPase antibody or non-immune serum but 
not in those from which first antibody was omitted. This 
was due to the presence of large quantities of IgG in 
immunoprecipitates, as shown by Western blotting with 
anti-rabbit IgG antibodies (data not shown). 32p-labelling 
of this IgG peak was probably due to non-specific interac- 
Table 2 
Effect of EDTA-treatment onribosomal, luminal protein and Ca 2 +,Mg- ATPase content of pancreatic rough ER membranes 
Fraction Protein content RNA content Amylase activity 
(mg/ml) (mg/ml) (U/ml) 
Ca 2+,Mg-ATPase activity 
enzymatic immunological 
(U/ml) (U/g.l) 
Untreated rough ER 7.09 + 2.20 (7) 4.83 + 1.11 (5) 162.1 + 35.7 (5) 18.9 + 12.5 (3) 4.81 + 0.57 (4) 
EDTA-treated membranes 2.09 4- 0.52 (8) 0.25 4- 0.06 (6) 12.0 + 2.8 (5) 4.5 4- 2.9 (3) 5.05 + 0.82 (4) 
Rough ER membranes were treated with EDTA as described in the text. Untreated membranes and pellets obtained after EDTA-treatment were assayed 
for RNA, amylase, Ca2+,Mg-ATPase enzymatic and immunological activity, as described in Materials and methods. Values are means 5= S.E. for the 
number of different membrane preparations denoted inparentheses. 
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Fig. 4. Densitometric trace of photoaffinity-labelled proteins immuno- 
precipitated by anti-SERCA-2b Ca2+,Mg-ATPase antibody. Pancreatic 
rough ER membranes were solubilized, immunoprecipitated either with 
anti-SERCA-2b Ca2+,Mg-ATPase antibody or non-immune IgG and 
photoaffinity-labelled in the presence of 5/xCi 8-azido-[a-32plATP for 
30 min, as described in the Materials and methods. Labelled samples 
were fractionated on 7.5% SDS-polyacrylamide g ls, autoradiographed 
and subjected to densitometric analysis, as described in Materials and 
methods. The peaks indicated by arrows correspond to two ATP-binding 
proteins of molecular mass 108 and 100 kDa, respectively, present in the 
anti-SERCA-2b Ca2+,Mg-ATPase (solid line) but not the non-immune 
IgG (dashed line) immunoprecipitate. The traces are from an autoradio- 
graph, representative of data from four different membrane preparations. 
tion between IgG and 8-azido-ATP since abundant sample 
components have been previously reported to bind photo- 
affinity reagent non-specifically [19,20]. 
4. Discussion 
In the present study, it has been shown that photo- 
affinity labelling with 8-azido-ATP can provide functional 
characterization of the Ca2+,Mg-ATPase and other ATP- 
binding proteins from pancreatic rough ER. Since 
Ca2+,Mg-ATPase activity is readily assayed in purified 
membranes, inhibition following covalent linkage of 8- 
azido-ATP has provided a simple monitor for optimization 
of labelling conditions (Figs. 1 and 2). 
Specificity of photoaffinity labelling was demonstrated 
in accord with criteria outlined by Haley [19]. Thus, 
labelling of Ca2+,Mg-ATPase and inhibition of activity 
were shown to be: (1) dependent on UV irradiation in the 
presence of 8-azido-ATP; (2) prevented by inclusion of 
excess substrate (5 mM ATP) during photoaffinity la- 
belling. In addition, rough ER membranes treated with 
EDTA retained immunological activity while > 80% of 
Ca2+,Mg-ATPase activity was abolished and photoaffinity 
labelling of the 111 and 100 kDa proteins was totally 
inhibited. Thus, the presence of inactive Ca2+,Mg-ATPase 
was insufficient for labelling to occur. Furthermore, the 
estimate of 97 /xM as the 8-azido-ATP concentration 
required for half-maximal inhibition of Ca2+,Mg-ATPase 
activity is in the same range as reported for the low-affin- 
ity binding site for ATP and the g m for activation of 
enzyme activity for ER Ca2+,Mg-ATPases [21]. The data 
suggest herefore that the low-affinity ATP-binding site is 
important for maximum activity of the pancreatic ER 
Ca2+,Mg-ATPase. The observation that inhibition of 
Ca2+,Mg-ATPase activity required up to 30 min of UV 
irradiation in the presence of 8-azido-ATP suggested that 
the mechanism for covalent binding, although specific, 
included an element of direct photoaffinity labelling in- 
volving free radical formation on aromatic amino acid 
residues [19]. 
Seven proteins were specifically radiolabelled by 8- 
azido-[tx-32 P]ATP (Fig. 3). Removal of ribosomes and 
luminal proteins by EDTA treatment resulted in loss of 
8-azido-[ a-32 P]ATP labelling of the four proteins of low- 
est molecular mass which was comparable to the loss of 
total protein (data not shown). This suggested that the four 
proteins were not intrinsic membrane proteins and, by 
comparison with a series of ATP-binding proteins from ER 
[22], the proteins of molecular mass 84, 69 and 55 kDa can 
be tentatively identified as BiP, ERP72 and protein disul- 
fide isomerase or calreticulin, respectively. The 47 kDa 
protein may correspond to an unidentified protein of simi- 
lar molecular mass detected as an ATP-binding luminal 
protein in ER [22] and SR [23]. The 141 kDa protein 
labelled by 8-azido-[a-32p]ATP is unlikely to be the 
plasma membrane Ca2+,Mg-ATPase since there is no de- 
tectable Na+,K+-ATPase in the rough ER preparation (see 
above and [24]) and because thapsigargin was shown to 
completely inhibit Ca2+,Mg-ATPase activity [1]. Also, the 
lack of effect of vanadate on ATP binding (Table 1) 
indicated that the 141 kDa protein is unlikely to be an 
ATPase and hence the SERCA-2b CaZ+,Mg-ATPase iso- 
forms are the only ATPases in pancreatic rER membranes. 
Previous immunological data [1] demonstrated that pan- 
creatic rough ER Ca2+,Mg-ATPases consisted of two iso- 
forms of SERCA-2b by virtue of possessing the C-terminal 
extension differentiating them from all other types 
[16,25,26]. The average molecular masses of the two iso- 
forms identified immunologically were 111 and 97 kDa 
[1], which corresponded closely to the molecular masses of 
two of the ATP-binding proteins detected by specific 
photoaffinity labelling in the present study. The demonstra- 
tion (Fig. 4) by photoaffinity labelling that ATP-binding 
proteins immunoprecipitated by the anti-SERCA-2b anti- 
body had similar molecular masses (approx. 108 and 100 
kDa) further confirmed the identification of these proteins 
as SERCA-2b Ca2÷,Mg-ATPase isoforms. 
In addition, the demonstration that the two rough ER 
SERCA-2b Ca2+,Mg-ATPase isoforms are susceptible to 
two inhibitors which act via different mechanisms further 
supports their identification as intact proteins which con- 
tain at least two of the domains known to be present in 
SERCA-2b ATPases. Thus, thapsigargin and vanadate in- 
hibited photoaffinity labelling and enzymatic activity of 
the two ATPases to differing degrees while the Na+,K ÷- 
ATPase inhibitor ouabain had no effect on either property. 
Vanadate has been shown to act as a phosphate analogue 
causing competitive inhibition of ATP binding to the 
active site of ATP-binding proteins [27]. Vanadate inhib- 
ited photoaffinity labelling of both isoforms by 60-70% at 
the same concentration (0.1 mM) which inhibited ATPase 
activity by approx. 92% [1]. Thus, the data suggest hat 
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inhibition of ATP-binding may contribute to the mecha- 
nism by which vanadate inhibits Ca2+,Mg-ATPase. The 
present data showed that thapsigargin had no effect on 
ATP-binding to the pancreatic SERCA-2b Ca2÷,Mg- 
ATPase isoforms (Fig. 3; Table 1), at a concentration that 
maximally inhibited Ca2÷,Mg-ATPase activity [1]. This is 
consistent with previous observations that ATP-binding 
regions of transport ATPases are highly conserved [9,28,29] 
yet thapsigargin s known to be a specific inhibitor of ER 
and SR Ca2+,Mg-ATPases [30-32]. Indeed, it has been 
suggested that thapsigargin produces a global effect on the 
enzymes, manifested by strong inhibition of Ca2÷-binding 
[33] and by the stabilization of the enzyme in a 'dead-end 
complex' [34,35], rather than by interaction with a specific 
domain. In the 'dead-end complex' conformation, the SR 
Ca2+,Mg-ATPase has a K m for ATP of approx. 90 /zM 
[36], which is similar to the concentration f photoaffinity 
reagent used in the present study (75/zM). This suggested 
that thapsigargin hibits the pancreatic enzyme by a simi- 
lar mechanism and stabilizes the enzyme such that only the 
'dead-end complex' site is exposed. 
Since, no differences in ATP-binding or immunological 
characteristics of the two Ca2÷,Mg-ATPase isoforms have 
been detected in the present or previous tudies [1], their 
physiological significance is not yet clear. The different 
isoforms may possess targeting information to direct them 
to distinct intracellular compartments. Thus, evidence that 
different Ca2÷,Mg-ATPase isoforms may account for Ca 2÷ 
uptake into different Ca 2+ stores has been obtained in 
adrenal chromaffin cells [10]. Further studies to elucidate 
differences in primary structure between the two isoforms 
will be facilitated by the ability to specifically label the 
ATP-binding sites and allow differences in function or 
intracellular location to be established. 
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